Provectus Biopharmaceutica-APVCT
13F holders, Q1 2026 (March 31)6holders +1
1new positions
0sold out
$0.05avg. 13F price*
At the end of Q1 2026, 6 institutions reported holding Provectus Biopharmaceutica-A (PVCT) in their 13F filings, up 1 from Q4 2025. 1 opened new positions and 0 sold out. The largest holders were Home Federal Bank of Tennessee ($5K), Wealth Preservation Advisors, LLC ($3K) and Academy Capital Management ($1K).
- Company
- Provectus Biopharmaceutica-A
- CUSIP
- 74373P108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $999 |
| Exits | 0 | $0 |
All 13F filers, Q4 2025 → Q1 2026: 19,620 shares bought, net +19,620 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Home Federal Bank of Tennessee | 0.00% | No change | 100,000 | $5K |
| Wealth Preservation Advisors, LLC | 0.00% | No change | 52,600 | $3K |
| Academy Capital Management | 0.00% | No change | 20,000 | $1K |
| Atlas Wealth LLC | 0.00% | New | 19,620 | $999 |
| Financial Symmetry Inc | 0.00% | No change | 10,191 | $581 |
| Huntington National Bank | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is PVCT's weight in each manager's 13F, not the share of Provectus Biopharmaceutica-A the manager owns.